Vorys, Sater, Seymour and Pease LLP
2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same
Provided is a 2-cyanopyrimidin-4-yl carbamate or urea derivative or pharmaceutically acceptable salt thereof, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The 2-cyanopyrimidin-4-yl carbamate or urea derivative or pharmaceutically acceptable salt thereof selectively inhibits cathepsin K and therefore can be usefully applied for preventing or treating osteoporosis.
HANLIM PHARMACEUTICAL CO., LTD.
C C C C C A C
C07D C07D C07D C07D C07D A61P C07D
inventional inventional inventional inventional inventional inventional inventional
Jun-Woo Ji-Hoon Ji-Hoon Eung-Seok Ju-Suk Jung-Wook Jung-Ae Sang-Hyun Kyung-Jin Tae-Cheon Shin-Ae Jae-Young Won-Seok Kyung-Hee
Kim Lee Yu Lee Lee Chin Kim Min Jung Jeong Kim Song Lee Kim